基于干细胞治疗骨关节炎的全球临床试验格局:趋势和转化影响

Xin Li1, Yue Zhao2, Dongsheng Guo1

  • 1Department of Orthopedics, The Affiliated Lianyungang Hospital of Xuzhou Medical University (The First People's Hospital of Lianyungang), Lianyungang, Jiangsu, China.

概括

骨关节炎干细胞治疗的全球临床试验正在增加,但不一致的设计和报告阻碍了疗效结论. 标准化和更长的随访对于转化这些再生医学方法至关重要.